cabotegravir
UkraineDrugs containing this active substance
-
The drug is intended for adults and children (from 12 years of age weighing at least 35 kg) who belong to a risk group, for the purpose of pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection through sexual contact.
Form: suspension for injection, prolonged action
Active substance Dosage cabotegravir 200 mg/ml ATC: J05AJ04
Manufacturer: Sterigenics Belgium SA (Sotera Health Company) (sterilization (gamma irradiation of API and finished product))
-
The drug is intended for adults and children aged 12 years and older (weighing at least 35 kg) who belong to a risk group, for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection through sexual contact.
Form: tablets, film-coated
Active substance Dosage cabotegravir 30 mg ATC: J05AJ04